The FDA approved obecabtagene autoleucel (obe-cel; Aucatzyl) for treating relapsed or refractory B-cell precursor acute ...

Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window ...

United States Cellular said on Thursday it has agreed to sell a portion of spectrum licenses used to transmit mobile phone ...

U.S. Cellular agreed to sell a portion of its retained spectrum licenses to AT&T for a consideration of $1.02 billion.

US Cellular Corp. agreed to sell some spectrum assets to AT&T Corp. for $1.02 billion as the tower operator continues the ...

Chicago-based United States Cellular Corp. on Thursday announced a deal to sell $1 billion in assets to AT&T Inc. The deal ...

United States Cellular (NYSE:USM) has agreed to sell a portion of its retained spectrum licenses to telecom giant AT&T ...

Though Trump was convicted of a felony in New York, it is a low-level offense and as a non-violent first-time offender (and ...

After selling to T-Mobile and Verizon, US Cellular has sold another chunk of its spectrum to AT&T now. Here’s what it could ...

The transaction is part of the regional wireless carrier's strategy to monetize its spectrum assets that were not part of the ...

FT836 incorporates multiple next-generation synthetic controls of CAR T-cell function including the Company's novel Sword & ...

AT&T will buy UScellular spectrum including 3.45 GHz and 700 MHz for $1 billion, as the latter prepares to sell its wireless ...